SCHEMBL9323708

SCHEMBL9323708

CCCC(=O)OCC(C)(C)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
DGKA P23743 1/20 0.39
LMNA P02545 3/20 0.36
HSD17B10 Q99714 1/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
PAM P19021 2/20 0.35
FFAR3 O14843 2/20 0.35
HDAC3 O15379 2/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC2 Q92769 2/20 0.35
HDAC8 Q9BY41 2/20 0.35
CYP1A2 P05177 1/20 0.34
TSHR P16473 3/20 0.33
MAPT P10636 1/20 0.33
NLRP3 Q96P20 1/20 0.33
DNM1 Q05193 1/20 0.32
CYP3A4 P08684 1/20 0.32
ATM Q13315 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22500496 0.88 ADRA1A (0.41) ALDH1A1DGKALMNAHSD17B10PAM
SCHEMBL7295297 0.85 DGKA (0.59) ALDH1A1DGKALMNACES2CES1
SCHEMBL3203892 0.84 ALDH1A1 (0.50) ALDH1A1DGKALMNAHSD17B10CES2
SCHEMBL8921697 0.84 ALDH1A1 (0.50) ALDH1A1DGKALMNAHSD17B10CES2
SCHEMBL517466 0.84 ALDH1A1 (0.50) ALDH1A1DGKALMNAHSD17B10CES2
SCHEMBL525482 0.81 ALDH1A1 (0.52) ALDH1A1DGKALMNAHSD17B10CES2
SCHEMBL10688843 0.80 ALDH1A1 (0.46) ALDH1A1DGKALMNAHSD17B10CES2
SCHEMBL6429699 0.80 ALDH1A1 (0.46) ALDH1A1DGKALMNAHSD17B10CES2
SCHEMBL27897028 0.80 ALDH1A1 (0.46) ALDH1A1DGKALMNAHSD17B10CES2
SCHEMBL13069324 0.79 ALDH1A1 (0.41) ALDH1A1DGKALMNAHSD17B10CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165258-A1 BIOCIDAL POLYURETHANE SYSTEMS, METHODS FOR THEIR PREPARATION AND USES THEREOF X-INFEX B.V. (NL) 2023-06-01 US disclosed
EP-0278090-B1 2-Aminoacetamide pyridinyl derivatives FISONS CORP (US) 1994-01-26 EP disclosed
EP-0278090-A2 2-Aminoacetamide pyridinyl derivatives FISONS CORPORATION (US) 1988-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165258-A1 BIOCIDAL POLYURETHANE SYSTEMS, METHODS FOR THEIR PREPARATION AND USES THEREOF PUF60, UNG, IDE ALDH1A1 853/4885DGKA 1409/4885LMNA 1588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.